IDEAS home Printed from https://ideas.repec.org/f/pru280.html
   My authors  Follow this author

Matteo Ruggeri

Personal Details

First Name:Matteo
Middle Name:
Last Name:Ruggeri
Suffix:
RePEc Short-ID:pru280
[This author has chosen not to make the email address public]

Research output

as
Jump to: Articles

Articles

  1. Matteo Ruggeri & Federica Romano & Michele Basile & Silvia Coretti & Francesca Romana Rolli & Carlo Drago & Americo Cicchetti, 2018. "Cost-Effectiveness Analysis of Early Treatment of Chronic HCV with Sofosbuvir/Velpatasvir in Italy," Applied Health Economics and Health Policy, Springer, vol. 16(5), pages 711-722, October.
  2. M. Ruggeri & M. Basile & C. Drago & F. R. Rolli & A. Cicchetti, 2018. "Cost-Effectiveness Analysis of Lesinurad/Allopurinol Versus Febuxostat for the Management of Gout/Hyperuricemia in Italy," PharmacoEconomics, Springer, vol. 36(5), pages 625-636, May.
  3. Paolo Massimo Buscema & Guido Maurelli & Francesco Saverio Mennini & Lara Gitto & Simone Russo & Matteo Ruggeri & Silvia Coretti & Americo Cicchetti, 2017. "Artificial neural networks and their potentialities in analyzing budget health data: an application for Italy of what-if theory," Quality & Quantity: International Journal of Methodology, Springer, vol. 51(3), pages 1261-1276, May.
  4. Mennini, Francesco Saverio & Gitto, Lara & Russo, Simone & Cicchetti, Americo & Ruggeri, Matteo & Coretti, Silvia & Maurelli, Guido & Buscema, Paolo Massimo, 2017. "Does regional belonging explain the similarities in the expenditure determinants of Italian healthcare deliveries?," Economic Analysis and Policy, Elsevier, vol. 55(C), pages 47-56.
  5. Paolo Massimo Buscema & Guido Maurelli & Francesco Saverio Mennini & Lara Gitto & Simone Russo & Matteo Ruggeri & Silvia Coretti & Americo Cicchetti, 2017. "Erratum to: Artificial neural networks and their potentialities in analyzing budget health data: an application for Italy of what-if theory," Quality & Quantity: International Journal of Methodology, Springer, vol. 51(3), pages 1277-1278, May.
  6. M. Ruggeri & M. Basile & S. Coretti & C. Drago & A. Cicchetti, 2017. "Economic Analysis and Budget Impact of Tenofovir and Entecavir in the First-Line Treatment of Hepatitis B Virus in Italy," Applied Health Economics and Health Policy, Springer, vol. 15(4), pages 479-490, August.
  7. Ruggeri, Matteo & Cicchetti, Americo & Gasbarrini, Antonio, 2011. "The cost-effectiveness of alternative strategies against HBV in Italy," Health Policy, Elsevier, vol. 102(1), pages 72-80, September.
  8. van der Pol, Marjon & Ruggeri, Matteo, 2008. "Is risk attitude outcome specific within the health domain?," Journal of Health Economics, Elsevier, vol. 27(3), pages 706-717, May.

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Articles

  1. Matteo Ruggeri & Federica Romano & Michele Basile & Silvia Coretti & Francesca Romana Rolli & Carlo Drago & Americo Cicchetti, 2018. "Cost-Effectiveness Analysis of Early Treatment of Chronic HCV with Sofosbuvir/Velpatasvir in Italy," Applied Health Economics and Health Policy, Springer, vol. 16(5), pages 711-722, October.

    Cited by:

    1. Andrea Marcellusi & Raffaella Viti & Loreta A. Kondili & Stefano Rosato & Stefano Vella & Francesco Saverio Mennini, 2019. "Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data," PharmacoEconomics, Springer, vol. 37(2), pages 255-266, February.
    2. Andrea Marcellusi & Francesco Saverio Mennini & Massimo Andreoni & Loreta A. Kondili, 2024. "Screening strategy to advance HCV elimination in Italy: a cost-consequence analysis," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 25(7), pages 1261-1273, September.
    3. Pingyu Chen & Min Jin & Yang Cao & Hongchao Li, 2021. "Cost-Effectiveness Analysis of Oral Direct-Acting Antivirals for Chinese Patients with Chronic Hepatitis C," Applied Health Economics and Health Policy, Springer, vol. 19(3), pages 371-387, May.
    4. Ru Han & Clément François & Mondher Toumi, 2021. "Systematic Review of Health State Utility Values Used in European Pharmacoeconomic Evaluations for Chronic Hepatitis C: Impact on Cost-Effectiveness Results," Applied Health Economics and Health Policy, Springer, vol. 19(1), pages 29-44, January.

  2. Mennini, Francesco Saverio & Gitto, Lara & Russo, Simone & Cicchetti, Americo & Ruggeri, Matteo & Coretti, Silvia & Maurelli, Guido & Buscema, Paolo Massimo, 2017. "Does regional belonging explain the similarities in the expenditure determinants of Italian healthcare deliveries?," Economic Analysis and Policy, Elsevier, vol. 55(C), pages 47-56.

    Cited by:

    1. Paolo Massimo Buscema & Guido Maurelli & Francesco Saverio Mennini & Lara Gitto & Simone Russo & Matteo Ruggeri & Silvia Coretti & Americo Cicchetti, 2017. "Artificial neural networks and their potentialities in analyzing budget health data: an application for Italy of what-if theory," Quality & Quantity: International Journal of Methodology, Springer, vol. 51(3), pages 1261-1276, May.

  3. M. Ruggeri & M. Basile & S. Coretti & C. Drago & A. Cicchetti, 2017. "Economic Analysis and Budget Impact of Tenofovir and Entecavir in the First-Line Treatment of Hepatitis B Virus in Italy," Applied Health Economics and Health Policy, Springer, vol. 15(4), pages 479-490, August.

    Cited by:

    1. Matteo Ruggeri & Federica Romano & Michele Basile & Silvia Coretti & Francesca Romana Rolli & Carlo Drago & Americo Cicchetti, 2018. "Cost-Effectiveness Analysis of Early Treatment of Chronic HCV with Sofosbuvir/Velpatasvir in Italy," Applied Health Economics and Health Policy, Springer, vol. 16(5), pages 711-722, October.
    2. M. Ruggeri & M. Basile & C. Drago & F. R. Rolli & A. Cicchetti, 2018. "Cost-Effectiveness Analysis of Lesinurad/Allopurinol Versus Febuxostat for the Management of Gout/Hyperuricemia in Italy," PharmacoEconomics, Springer, vol. 36(5), pages 625-636, May.

  4. Ruggeri, Matteo & Cicchetti, Americo & Gasbarrini, Antonio, 2011. "The cost-effectiveness of alternative strategies against HBV in Italy," Health Policy, Elsevier, vol. 102(1), pages 72-80, September.

    Cited by:

    1. Daniel T Myran & Rachael Morton & Beverly-Ann Biggs & Irene Veldhuijzen & Francesco Castelli & Anh Tran & Lukas P Staub & Eric Agbata & Prinon Rahman & Manish Pareek & Teymur Noori & Kevin Pottie, 2018. "The Effectiveness and Cost-Effectiveness of Screening for and Vaccination Against Hepatitis B Virus among Migrants in the EU/EEA: A Systematic Review," IJERPH, MDPI, vol. 15(9), pages 1-19, September.
    2. Claudia Geue & Olivia Wu & Yiqiao Xin & Robert Heggie & Sharon Hutchinson & Natasha K Martin & Elisabeth Fenwick & David Goldberg & Consortium and ECDC, 2015. "Cost-Effectiveness of HBV and HCV Screening Strategies – A Systematic Review of Existing Modelling Techniques," PLOS ONE, Public Library of Science, vol. 10(12), pages 1-26, December.

  5. van der Pol, Marjon & Ruggeri, Matteo, 2008. "Is risk attitude outcome specific within the health domain?," Journal of Health Economics, Elsevier, vol. 27(3), pages 706-717, May.

    Cited by:

    1. Arthur E. Attema & Olivier L’Haridon & Gijs Kuilen, 2023. "An experimental investigation of social risk preferences for health," Theory and Decision, Springer, vol. 95(3), pages 379-403, October.
    2. Emmanuel Kemel & Corina Paraschiv, 2018. "Deciding about human lives: an experimental measure of risk attitudes under prospect theory," Social Choice and Welfare, Springer;The Society for Social Choice and Welfare, vol. 51(1), pages 163-192, June.
    3. Murong Yang & Laurence S. J. Roope & James Buchanan & Arthur E. Attema & Philip M. Clarke & A. Sarah Walker & Sarah Wordsworth, 2022. "Eliciting risk preferences that predict risky health behavior: A comparison of two approaches," Health Economics, John Wiley & Sons, Ltd., vol. 31(5), pages 836-858, May.
    4. Marco Caliendo & Deborah A. Cobb-Clark & Cosima Obst & Arne Uhlendorff, 2020. "Risk Preferences and Training Investments," SOEPpapers on Multidisciplinary Panel Data Research 1113, DIW Berlin, The German Socio-Economic Panel (SOEP).
    5. Joseph G Eisenhauer, 2012. "Measuring Aversion to Health Risks," Journal of Economics and Behavioral Studies, AMH International, vol. 4(2), pages 96-107.
    6. Stefan A. Lipman & Arthur E. Attema, 2019. "Rabin's paradox for health outcomes," Health Economics, John Wiley & Sons, Ltd., vol. 28(8), pages 1064-1071, August.
    7. Jifei Wu & Xiangyun Zhang & Yimin Zhu & Grace Fang Yu-Buck, 2021. "Get Close to the Robot: The Effect of Risk Perception of COVID-19 Pandemic on Customer–Robot Engagement," IJERPH, MDPI, vol. 18(12), pages 1-17, June.
    8. Zhu, Xuemin & van der Pol, Marjon & Scott, Anthony & Allan, Julia, 2023. "The stability of physicians’ risk attitudes across time and domains," Social Science & Medicine, Elsevier, vol. 339(C).
    9. Cornel Kaufmann & Tobias Mueller & Andreas Hefti & Stefan Boes, 2018. "Does personalized information improve health plan choices when individuals are distracted?," Diskussionsschriften dp1808, Universitaet Bern, Departement Volkswirtschaft.
    10. Michael Grimm & Carole Treibich, 2013. "Why Do Some Bikers Wear a Helmet and Others Don't? Evidence from Delhi, India," AMSE Working Papers 1348, Aix-Marseille School of Economics, France, revised 10 Oct 2013.
    11. Vetter, Stefan & Heiss, Florian & McFadden, Daniel L. & Winter, Joachim, 2013. "Risk attitudes and Medicare Part D enrollment decisions," Munich Reprints in Economics 19703, University of Munich, Department of Economics.
    12. van der Pol, Marjon & Walsh, David & McCartney, Gerry, 2015. "Comparing time and risk preferences across three post-industrial UK cities," Social Science & Medicine, Elsevier, vol. 140(C), pages 54-61.
    13. Matteo M. Galizzi, 2014. "What Is Really Behavioral in Behavioral Health Policy? And Does It Work?," Applied Economic Perspectives and Policy, Agricultural and Applied Economics Association, vol. 36(1), pages 25-60.
    14. Michael Grimm & Carole Treibich, 2016. "Why do some motorbike riders wear a helmet and others don’t? Evidence from Delhi, India," Post-Print hal-01440287, HAL.
    15. Sophie Massin & Antoine Nebout & Bruno Ventelou, 2018. "Predicting medical practices using various risk attitude measures," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(6), pages 843-860, July.
    16. Sven Tengstam, 2014. "Disability And Marginal Utility Of Income: Evidence From Hypothetical Choices," Health Economics, John Wiley & Sons, Ltd., vol. 23(3), pages 268-282, March.
    17. Kris De Jaegher, 2019. "Strategic framing to influence clients’ risky decisions," Theory and Decision, Springer, vol. 86(3), pages 437-462, May.
    18. Yu Gao & Zhenxing Huang & Ning Liu & Jia Yang, 2024. "Are physicians rational under ambiguity?," Journal of Risk and Uncertainty, Springer, vol. 68(2), pages 183-203, April.
    19. Tayyari Dehbarez, Nasrin & Gyrd-Hansen, Dorte & Uldbjerg, Niels & Søgaard, Rikke, 2018. "Does free choice of hospital conflict with equity of access to highly specialized hospitals? A case study from the Danish health care system," Health Policy, Elsevier, vol. 122(7), pages 722-727.
    20. Marjon van der Pol, 2011. "Health, education and time preference," Health Economics, John Wiley & Sons, Ltd., vol. 20(8), pages 917-929, August.
    21. Glenn W. Harrison & Andre Hofmeyr & Don Ross & J. Todd Swarthout, 2018. "Risk Preferences, Time Preferences, and Smoking Behavior," Southern Economic Journal, John Wiley & Sons, vol. 85(2), pages 313-348, October.
    22. Petrolia, Daniel, 2015. "Risk Preferences, Risk Perceptions, and Risky Food," Working Papers 212481, Mississippi State University, Department of Agricultural Economics.
    23. Cruz Rambaud, Salvador & Ortiz Fernández, Piedad & Parra Oller, Isabel María, 2023. "A systematic review of the main anomalies in intertemporal choice," Journal of Behavioral and Experimental Economics (formerly The Journal of Socio-Economics), Elsevier, vol. 104(C).
    24. Matteo Ruggeri & Carlo Drago, 2021. "Is risk attitude toward health outcomes context driven?," Quality & Quantity: International Journal of Methodology, Springer, vol. 55(1), pages 63-77, February.
    25. Alejandro Arrieta & Ariadna García-Prado & Paula González & Jose Luis Pinto-Prades, 2016. "Risk Attitudes in Medical Decisions for Others: An Experimental Approach," Working Papers 16.07, Universidad Pablo de Olavide, Department of Economics.
    26. Rouyard, Thomas & Attema, Arthur & Baskerville, Richard & Leal, José & Gray, Alastair, 2018. "Risk attitudes of people with ‘manageable’ chronic disease: An analysis under prospect theory," Social Science & Medicine, Elsevier, vol. 214(C), pages 144-153.
    27. Galizzi, Matteo M. & Miraldo, Marisa & Stavropoulou, Charitini & van der Pol, Marjon, 2016. "Doctor–patient differences in risk and time preferences: a field experiment," LSE Research Online Documents on Economics 68143, London School of Economics and Political Science, LSE Library.
    28. Miraldo, M & Galizzi, M & Stavropoulou, C, 2013. "Doctor-patient differences in risk preferences, and their links to decision-making: a field experiment," Working Papers 12578, Imperial College, London, Imperial College Business School.
    29. Grimm, M. & Treibich, C., 2010. "Socio-economic determinants of road traffic accident fatalities in low and middle income countries," ISS Working Papers - General Series 19841, International Institute of Social Studies of Erasmus University Rotterdam (ISS), The Hague.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Co-authorship network on CollEc

Featured entries

This author is featured on the following reading lists, publication compilations, Wikipedia, or ReplicationWiki entries:
  1. Associazione Italiana di Economia Sanitaria - AIES

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Matteo Ruggeri should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.